Navigation überspringen
Universitätsbibliothek Heidelberg
Standort: ---
Exemplare: ---
heiBIB
 Online-Ressource
Verfasst von:Pfob, André [VerfasserIn]   i
 Barr, Richard G. [VerfasserIn]   i
 Duda, Volker [VerfasserIn]   i
 Büsch, Christopher [VerfasserIn]   i
 Bruckner, Thomas [VerfasserIn]   i
 Spratte, Julia [VerfasserIn]   i
 Nees, Juliane [VerfasserIn]   i
 Togawa, Riku [VerfasserIn]   i
 Ho, Chi [VerfasserIn]   i
 Fastner, Sarah [VerfasserIn]   i
 Riedel, Fabian [VerfasserIn]   i
 Schäfgen, Benedikt [VerfasserIn]   i
 Hennigs, André [VerfasserIn]   i
 Sohn, Christof [VerfasserIn]   i
 Heil, Jörg [VerfasserIn]   i
 Golatta, Michael [VerfasserIn]   i
Titel:A new practical decision rule to better differentiate BI-RADS 3 or 4 breast masses on breast ultrasound
Verf.angabe:André Pfob, Richard G. Barr, Volker Duda, Christopher Büsch, Thomas Bruckner, Julia Spratte, Juliane Nees, Riku Togawa, Chi Ho, Sarah Fastner, Fabian Riedel, Benedikt Schaefgen, André Hennigs, Christof Sohn, Joerg Heil, Michael Golatta
Jahr:2022
Umfang:10 S.
Fussnoten:First published: 04 May 2021 ; Gesehen am 04.09.2023
Titel Quelle:Enthalten in: Journal of ultrasound in medicine
Ort Quelle:Hoboken, NJ : Wiley, 1982
Jahr Quelle:2022
Band/Heft Quelle:41(2022), 2, Seite 427-436
ISSN Quelle:1550-9613
Abstract:Objectives The BI-RADS classification provides a standardized way to describe ultrasound findings in breast cancer diagnostics. However, there is little information regarding which BI-RADS descriptors are most strongly associated with malignancy, to better distinguish BI-RADS 3 (follow-up imaging) and 4 (diagnostic biopsy) breast masses. Methods Patients were recruited as part of an international, multicenter trial (NCT02638935). The trial enrolled 1294 women (6 excluded) categorized as BI-RADS 3 or 4 upon routine B-mode ultrasound examination. Ultrasound images were evaluated by three expert physicians according to BI-RADS. All patients underwent histopathological confirmation (reference standard). We performed univariate and multivariate analyses (chi-square test, logistic regression, and Krippendorff's alpha). Results Histopathologic evaluation showed malignancy in 368 of 1288 masses (28.6%). Upon performing multivariate analysis, the following descriptors were significantly associated with malignancy (P < .05): age ≥50 years (OR 8.99), non-circumscribed indistinct (OR 4.05) and microlobulated margin (OR 2.95), nonparallel orientation (OR 2.69), and calcification (OR 2.64). A clinical decision rule informed by these results demonstrated a 97% sensitivity and missed fewer cancers compared to three physician experts (range of sensitivity 79-95%) and a previous decision rule (sensitivity 59%). Specificity was 44% versus 22-83%, respectively. The inter-reader reliability of the BI-RADS descriptors and of the final BI-RADS score was fair-moderate. Conclusions A patient should undergo a diagnostic biopsy (BI-RADS 4) instead of follow-up imaging (BI-RADS 3) if the patient is 50 years or older or exhibits at least one of the following features: calcification, nonparallel orientation of mass, non-circumscribed margin, or posterior shadowing.
DOI:doi:10.1002/jum.15722
URL:kostenfrei: Volltext: https://doi.org/10.1002/jum.15722
 kostenfrei: Volltext: https://onlinelibrary.wiley.com/doi/abs/10.1002/jum.15722
 DOI: https://doi.org/10.1002/jum.15722
Datenträger:Online-Ressource
Sprache:eng
Sach-SW:BI-RADS
 breast mass
 decision rule
 malignancy
 reliability
 ultrasound
K10plus-PPN:1858725135
Verknüpfungen:→ Zeitschrift
 
 
Lokale URL UB: Zum Volltext

Permanenter Link auf diesen Titel (bookmarkfähig):  https://katalog.ub.uni-heidelberg.de/titel/69118248   QR-Code
zum Seitenanfang